Brez internetne povezave — prikazana je shranjena različica strani.
← k velikim vlagateljem

Rhenman & Partners Asset Management AB

upravljavec premoženja · portfelj $1.06 mrd. · 99 pozicij · poročilo na dan 30.06.2026

Pozicije v delnicah poročilo za 30.06.2026, oddano 13.08.2026; sprememba — v primerjavi z 31.03.2026 · 107

PodjetjeDelniceVrednost% portfeljaSprememba v četrtletju
UNITEDHEALTH GROUP INC
US:UNH
93 600$38.9 mio.3.67%+48 100
CVS Health Corp
US:CVS
279 374$28.9 mio.2.73%−57 126
ASTRAZENECA PLC
CUSIP G0593M107
151 500$28.5 mio.2.69%nova
MERCK & CO INC
US:MRK
213 500$27.4 mio.2.59%nova
Eli Lilly and Company
US:LLY
22 315$26.8 mio.2.53%−11 400
AbbVie Inc
US:ABBV
96 775$24.4 mio.2.30%+25 200
Alignment Healthcare LLC
US:ALHC
997 083$23.7 mio.2.24%−56 367
Edwards Lifesciences Corp
US:EW
260 000$23.5 mio.2.22%+97 000
Gilead Sciences Inc
US:GILD
178 250$22.5 mio.2.13%+10 500
JAZZ PHARMACEUTICALS PLC
CUSIP G50871105
87 440$21.1 mio.1.99%+11 550
Biogen Inc
US:BIIB
94 850$20.5 mio.1.93%−14 250
STRYKER CORP
US:SYK
65 000$20.5 mio.1.93%+17 200
Boston Scientific Corp
US:BSX
450 500$19.2 mio.1.81%−174 500
Johnson & Johnson
US:JNJ
72 500$18.4 mio.1.74%nova
Guardant Health Inc
US:GH
115 000$17.3 mio.1.63%−30 000
Regeneron Pharmaceuticals In…
US:REGN
27 390$17.1 mio.1.61%−20 710
Glaukos Corp
US:GKOS
119 000$16.6 mio.1.57%+35 000
Biomarin Pharmaceutical Inc
US:BMRN
290 500$16.6 mio.1.57%+83 500
Nurix Therapeutics Inc
US:NRIX
684 250$16.6 mio.1.57%+370 750
Natera, Inc.
US:NTRA
61 050$16.6 mio.1.56%+9 450
Mirum Pharmaceuticals Inc
US:MIRM
139 205$16.3 mio.1.54%+46 600
Insmed Inc
US:INSM
151 960$16.2 mio.1.53%−7 800
Tenet Healthcare Corporation
US:THC
85 200$15.9 mio.1.50%+31 200
Thermo Fisher Scientific Inc
US:TMO
31 580$15.8 mio.1.49%−9 760
Centene Corp
US:CNC
244 000$15.7 mio.1.48%nova
Axsome Therapeutics Inc
US:AXSM
63 050$15.4 mio.1.46%−750
Danaher Corporation
US:DHR
80 252$15.3 mio.1.44%+62 200
Vertex Pharmaceuticals Inc
US:VRTX
30 685$15.2 mio.1.44%−12 800
Anteris Technologies Global…
US:AVR
1 538 625$15.2 mio.1.43%+100 000
Neurocrine Biosciences Inc
US:NBIX
85 841$14.5 mio.1.37%−15 000
oglas